---
title: "CF PharmTech, Inc. (02652.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02652.HK.md"
symbol: "02652.HK"
name: "CF PharmTech, Inc."
industry: "Pharmaceuticals"
---

# CF PharmTech, Inc. (02652.HK)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | HK Market |
| Website | [www.cfpharmtech.com](https://www.cfpharmtech.com) |

## Company Profile

CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs in the field of respiratory diseases in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 472.60 | 33/51 | 487.16 | 468.54 | 407.16 |
| PB | 13.68 | 45/51 | 14.10 | 13.56 | 11.79 |
| PS (TTM) | 21.72 | 45/51 | 22.39 | 21.53 | 18.71 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/02652.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02652.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02652.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.